1. Home
  2. AMSC vs DYN Comparison

AMSC vs DYN Comparison

Compare AMSC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMSC
  • DYN
  • Stock Information
  • Founded
  • AMSC 1987
  • DYN 1984
  • Country
  • AMSC United States
  • DYN United States
  • Employees
  • AMSC N/A
  • DYN 191
  • Industry
  • AMSC Metal Fabrications
  • DYN Medicinal Chemicals and Botanical Products
  • Sector
  • AMSC Consumer Discretionary
  • DYN Health Care
  • Exchange
  • AMSC Nasdaq
  • DYN Nasdaq
  • Market Cap
  • AMSC 793.5M
  • DYN 1.3B
  • IPO Year
  • AMSC 1991
  • DYN 2020
  • Fundamental
  • Price
  • AMSC $21.60
  • DYN $11.41
  • Analyst Decision
  • AMSC Strong Buy
  • DYN Strong Buy
  • Analyst Count
  • AMSC 3
  • DYN 12
  • Target Price
  • AMSC $33.67
  • DYN $47.00
  • AVG Volume (30 Days)
  • AMSC 415.7K
  • DYN 2.9M
  • Earning Date
  • AMSC 05-28-2025
  • DYN 05-08-2025
  • Dividend Yield
  • AMSC N/A
  • DYN N/A
  • EPS Growth
  • AMSC N/A
  • DYN N/A
  • EPS
  • AMSC 0.09
  • DYN N/A
  • Revenue
  • AMSC $198,191,000.00
  • DYN N/A
  • Revenue This Year
  • AMSC $51.58
  • DYN N/A
  • Revenue Next Year
  • AMSC $16.67
  • DYN N/A
  • P/E Ratio
  • AMSC $238.36
  • DYN N/A
  • Revenue Growth
  • AMSC 46.42
  • DYN N/A
  • 52 Week Low
  • AMSC $13.07
  • DYN $6.36
  • 52 Week High
  • AMSC $38.02
  • DYN $47.45
  • Technical
  • Relative Strength Index (RSI)
  • AMSC 61.07
  • DYN 55.69
  • Support Level
  • AMSC $20.13
  • DYN $9.17
  • Resistance Level
  • AMSC $21.64
  • DYN $12.47
  • Average True Range (ATR)
  • AMSC 0.99
  • DYN 0.96
  • MACD
  • AMSC 0.31
  • DYN 0.13
  • Stochastic Oscillator
  • AMSC 93.62
  • DYN 67.88

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet world's demand for smarter, cleaner and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: